Literature DB >> 18618016

Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats.

Hiraku Ono1, Alessandro Pocai, Yuhua Wang, Hideyuki Sakoda, Tomoichiro Asano, Jonathan M Backer, Gary J Schwartz, Luciano Rossetti.   

Abstract

Prolonged activation of p70 S6 kinase (S6K) by insulin and nutrients leads to inhibition of insulin signaling via negative feedback input to the signaling factor IRS-1. Systemic deletion of S6K protects against diet-induced obesity and enhances insulin sensitivity in mice. Herein, we present evidence suggesting that hypothalamic S6K activation is involved in the pathogenesis of diet-induced hepatic insulin resistance. Extending previous findings that insulin suppresses hepatic glucose production (HGP) partly via its effect in the hypothalamus, we report that this effect was blunted by short-term high-fat diet (HFD) feeding, with concomitant suppression of insulin signaling and activation of S6K in the mediobasal hypothalamus (MBH). Constitutive activation of S6K in the MBH mimicked the effect of the HFD in normal chow-fed animals, while suppression of S6K by overexpression of dominant-negative S6K or dominant-negative raptor in the MBH restored the ability of MBH insulin to suppress HGP after HFD feeding. These results suggest that activation of hypothalamic S6K contributes to hepatic insulin resistance in response to short-term nutrient excess.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618016      PMCID: PMC2447927          DOI: 10.1172/JCI34277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Overfeeding rapidly induces leptin and insulin resistance.

Authors:  J Wang; S Obici; K Morgan; N Barzilai; Z Feng; L Rossetti
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

2.  Central administration of oleic acid inhibits glucose production and food intake.

Authors:  Silvana Obici; Zhaohui Feng; Kimyata Morgan; Daniel Stein; George Karkanias; Luciano Rossetti
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

3.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  Hypothalamic insulin signaling is required for inhibition of glucose production.

Authors:  Silvana Obici; Bei B Zhang; George Karkanias; Luciano Rossetti
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

5.  The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.

Authors:  Hiroki Nojima; Chiharu Tokunaga; Satoshi Eguchi; Noriko Oshiro; Sujuti Hidayat; Ken-ichi Yoshino; Kenta Hara; Noriaki Tanaka; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

6.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

7.  Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.

Authors:  Janice M Zabolotny; Young-Bum Kim; Laura A Welsh; Erin E Kershaw; Benjamin G Neel; Barbara B Kahn
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

8.  Hepatic overexpression of a dominant negative form of raptor enhances Akt phosphorylation and restores insulin sensitivity in K/KAy mice.

Authors:  Yuko Koketsu; Hideyuki Sakoda; Midori Fujishiro; Akifumi Kushiyama; Yasushi Fukushima; Hiraku Ono; Motonobu Anai; Takako Kikuchi; Takeshi Fukuda; Hideaki Kamata; Nanao Horike; Yasunobu Uchijima; Hiroki Kurihara; Tomoichiro Asano
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

9.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production.

Authors:  Silvana Obici; Zhaohui Feng; Arduino Arduini; Roberto Conti; Luciano Rossetti
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

Review 10.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

View more
  77 in total

Review 1.  Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?

Authors:  Asish K Saha; X Julia Xu; Thomas W Balon; Amanda Brandon; Edward W Kraegen; Neil B Ruderman
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

2.  Brain insulin controls adipose tissue lipolysis and lipogenesis.

Authors:  Thomas Scherer; James O'Hare; Kelly Diggs-Andrews; Martina Schweiger; Bob Cheng; Claudia Lindtner; Elizabeth Zielinski; Prashant Vempati; Kai Su; Shveta Dighe; Thomas Milsom; Michelle Puchowicz; Ludger Scheja; Rudolf Zechner; Simon J Fisher; Stephen F Previs; Christoph Buettner
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

3.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

4.  Pim3 negatively regulates glucose-stimulated insulin secretion.

Authors:  Gregory Vlacich; Martijn C Nawijn; Gene C Webb; Donald F Steiner
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

Review 5.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

Review 6.  Evidence for central regulation of glucose metabolism.

Authors:  Michelle Carey; Sylvia Kehlenbrink; Meredith Hawkins
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

7.  Altered metabolism and resistance to obesity in long-lived mice producing reduced levels of IGF-I.

Authors:  Adam B Salmon; Chad Lerner; Yuji Ikeno; Susan M Motch Perrine; Roger McCarter; Christian Sell
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-03       Impact factor: 4.310

8.  Modulation of hypothalamic S6K1 and S6K2 alters feeding behavior and systemic glucose metabolism.

Authors:  Mariana Rosolen Tavares; Simone Ferreira Lemes; Thais de Fante; Cristina Saenz de Miera; Isadora Carolina Betim Pavan; Rosangela Maria Neves Bezerra; Patricia Oliveira Prada; Marcio Alberto Torsoni; Carol Fuzeti Elias; Fernando Moreira Simabuco
Journal:  J Endocrinol       Date:  2020-01-01       Impact factor: 4.286

9.  Central prolactin receptors (PRLRs) regulate hepatic insulin sensitivity in mice via signal transducer and activator of transcription 5 (STAT5) and the vagus nerve.

Authors:  Fei Xiao; Tingting Xia; Ziquan Lv; Qian Zhang; Yuzhong Xiao; Junjie Yu; Hao Liu; Jiali Deng; Yajie Guo; Chunxia Wang; Kai Li; Bin Liu; Shanghai Chen; Feifan Guo
Journal:  Diabetologia       Date:  2014-07-28       Impact factor: 10.122

10.  Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance.

Authors:  Louise E Olofsson; Elizabeth K Unger; Clement C Cheung; Allison W Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.